HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen L Atkin Selected Research

24,25-Dihydroxyvitamin D 3 (24,25 Dihydroxyvitamin D 3)

1/2021Relationship between total vitamin D metabolites and complications in patients with type 2 diabetes.
1/2020Association of vitamin D3 and its metabolites in patients with and without type 2 diabetes and their relationship to diabetes complications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen L Atkin Research Topics

Disease

50Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
04/2022 - 02/2002
46Type 2 Diabetes Mellitus (MODY)
10/2022 - 10/2002
44Insulin Resistance
01/2022 - 10/2002
25Inflammation (Inflammations)
06/2021 - 01/2009
17Weight Loss (Weight Reduction)
10/2022 - 12/2008
17Hypoglycemia (Reactive Hypoglycemia)
01/2022 - 05/2007
16COVID-19
01/2022 - 09/2020
13Neoplasms (Cancer)
06/2021 - 02/2002
13Obesity
01/2021 - 01/2007
12Diabetes Complications
01/2021 - 01/2019
8Atherosclerosis
10/2020 - 01/2007
7Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2007
7Non-alcoholic Fatty Liver Disease
06/2021 - 06/2014
7Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019 - 07/2006
6Diabetes Mellitus
06/2021 - 01/2019
6Overweight
03/2021 - 01/2019
6Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 01/2007
5Hypothyroidism
11/2022 - 05/2006
5Body Weight (Weight, Body)
10/2022 - 02/2016
5Vitamin D Deficiency
11/2021 - 05/2020
5Diabetic Nephropathies (Diabetic Nephropathy)
10/2021 - 12/2017
5Hyperglycemia
01/2020 - 10/2009
4Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021 - 10/2009
4Dyslipidemias (Dyslipidemia)
01/2021 - 01/2020
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 01/2007
4Infertility (Sterility)
01/2021 - 01/2019
4Gestational Diabetes (Gestational Diabetes Mellitus)
01/2021 - 01/2019
4Chronic Renal Insufficiency
01/2019 - 11/2010
3Hyperthyroidism
11/2022 - 04/2003
3Hypoxia (Hypoxemia)
11/2021 - 11/2018
3Morbid Obesity
01/2021 - 03/2014
3Dementia (Dementias)
01/2021 - 01/2021
3Hypertension (High Blood Pressure)
01/2021 - 01/2020
3Infections
01/2021 - 01/2019
3Reperfusion Injury
01/2019 - 01/2018
3Hyperprolactinemia
03/2018 - 01/2007
3Heart Failure
01/2018 - 05/2006
3Adenoma (Adenomas)
06/2013 - 01/2007
2Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
06/2022 - 01/2022
2Endocrine System Diseases (Endocrine Diseases)
04/2022 - 06/2012

Drug/Important Bio-Agent (IBA)

26Glucose (Dextrose)FDA LinkGeneric
10/2022 - 07/2006
22Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2004
22Insulin (Novolin)FDA Link
04/2021 - 10/2002
21Proteins (Proteins, Gene)FDA Link
02/2022 - 12/2017
15C-Reactive ProteinIBA
01/2022 - 10/2005
14AndrogensIBA
04/2022 - 12/2008
14LipidsIBA
01/2022 - 01/2009
13Metformin (Glucophage)FDA LinkGeneric
01/2022 - 12/2008
12Vitamin DFDA LinkGeneric
11/2021 - 12/2002
12CurcuminIBA
01/2021 - 01/2017
11Hypoglycemic Agents (Hypoglycemics)IBA
11/2021 - 04/2013
10Testosterone (Sustanon)FDA Link
03/2021 - 12/2008
9MicroRNAs (MicroRNA)IBA
10/2020 - 01/2018
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2021 - 01/2009
8CytokinesIBA
01/2021 - 01/2010
8Atorvastatin (Lipitor)FDA Link
01/2019 - 01/2009
7IsoflavonesIBA
01/2019 - 10/2002
6Blood Glucose (Blood Sugar)IBA
11/2021 - 01/2018
6CholesterolIBA
06/2021 - 10/2002
6AdipokinesIBA
01/2021 - 01/2017
6Hormones (Hormone)IBA
01/2019 - 12/2002
6Biological ProductsIBA
01/2019 - 11/2002
5Triglycerides (Triacylglycerol)IBA
01/2021 - 01/2009
5RimonabantIBA
07/2017 - 12/2008
4oxidized low density lipoproteinIBA
10/2022 - 01/2018
4hydroxide ionIBA
01/2021 - 01/2020
4Amyloid (Amyloid Fibrils)IBA
01/2021 - 12/2018
4Cholecalciferol (Vitamin D3)FDA Link
01/2021 - 01/2020
4Peptides (Polypeptides)IBA
01/2019 - 03/2010
4Somatostatin Receptors (Somatostatin Receptor)IBA
06/2013 - 11/2005
3Thyroxine (Levothyroxine)FDA LinkGeneric
11/2022 - 10/2002
3Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2022 - 01/2021
3Exenatide (Byetta)FDA Link
01/2022 - 01/2018
3IncretinsIBA
09/2021 - 01/2021
3Therapeutic UsesIBA
06/2021 - 05/2019
3AlbuminsIBA
03/2021 - 12/2017
3CalciumIBA
03/2021 - 12/2002
3Neuropilin-1IBA
03/2021 - 11/2005
3Hemoglobins (Hemoglobin)IBA
03/2021 - 02/2017
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2019
3HDL LipoproteinsIBA
01/2021 - 05/2017
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 11/2005
3Complement System Proteins (Complement)IBA
01/2021 - 01/2021
3empagliflozinIBA
06/2020 - 01/2018
3Free RadicalsIBA
01/2020 - 01/2019
3Alanine Transaminase (SGPT)IBA
01/2019 - 07/2017
3Sodium-Glucose Transport ProteinsIBA
01/2019 - 01/2018
3HDL CholesterolIBA
01/2019 - 10/2002
3Soybean Proteins (Soy Protein)IBA
01/2019 - 10/2002
3Dopamine Agonists (Dopamine Agonist)IBA
03/2018 - 01/2007
3Insulin Glargine (Lantus)FDA Link
01/2018 - 04/2013
3Glucagon-Like Peptide 1 (GLP 1)IBA
01/2018 - 03/2010
3Phytoestrogens (Phytoestrogen)IBA
01/2018 - 10/2002
3EndocannabinoidsIBA
07/2017 - 10/2016
3LiraglutideFDA Link
02/2016 - 04/2015
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
06/2013 - 11/2005
2KetonesIBA
06/2022 - 01/2022

Therapy/Procedure

28Therapeutics
01/2022 - 01/2007
14Glycemic Control
01/2021 - 10/2002
6Bariatric Surgery
01/2021 - 03/2014